ITPRIP and Alzheimer disease: Reduction of IP3R–mediated calcium signaling rescued presenilin-associated AD pathogenesis in mouse models [59], thus drugs that enhance ITPRIP activity may prevent cell death in neurodegenerative diseases and stroke [58].